Laboratory Diagnosis of Activated Protein C Resistance and Factor V Leiden.
Bahraini M, Fazeli A, Dorgalaleh A.
Semin Thromb Hemost. 2024 Nov;50(8):1067-1083. doi: 10.1055/s-0043-1770773. Epub 2023 Jul 10.
Activated Protein C Resistance Testing: An Update From Australasia/Asia-Pacific.
Favaloro EJ, Arunachalam S, Dean E, Salwa M, Ahuja M, Connelly L, Chapman K, Vong R, Pasalic L.
Int J Lab Hematol. 2025 Aug;47(4):720-729. doi: 10.1111/ijlh.14447. Epub 2025 Feb 19.
Laboratory Testing for Activated Protein C Resistance (APCR): An Update.
Favaloro EJ, Mohammed S, Vong R, Pasalic L.
Methods Mol Biol. 2023;2663:203-210. doi: 10.1007/978-1-0716-3175-1_11.
Activated protein C resistance and factor V Leiden: a review.
Rosendorff A, Dorfman DM.
Arch Pathol Lab Med. 2007 Jun;131(6):866-71. doi: 10.5858/2007-131-866-APCRAF.
Activated protein C resistance and myocardial infarction.
Laffan MA.
Heart. 1998 Oct;80(4):319-21. doi: 10.1136/hrt.80.4.319.
Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states.
Nicolaes GA, Dahlbäck B.
Hematol Oncol Clin North Am. 2003 Feb;17(1):37-61, vi. doi: 10.1016/s0889-8588(02)00097-7.
Congenital and acquired activated protein C resistance.
Nicolaes GA, Dahlbäck B.
Semin Vasc Med. 2003 Feb;3(1):33-46. doi: 10.1055/s-2003-38331.
Activated protein C resistance, the factor V Leiden mutation, and a laboratory testing algorithm.
Van Cott EM, Soderberg BL, Laposata M.
Arch Pathol Lab Med. 2002 May;126(5):577-82. doi: 10.5858/2002-126-0577-APCRTF.
Activated protein C resistance and pregnancy loss.
Dawood F, Farquharson R, Quenby S.
Hosp Med. 2003 Jan;64(1):24-7. doi: 10.12968/hosp.2003.64.1.1840.
Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B.
Semin Thromb Hemost. 1999;25(3):273-89. doi: 10.1055/s-2007-994931.
